Location:  Home » Biomedical Engineering » Nanomedicine, Vol. I: Basic Capabilities    

Nanomedicine, Vol. I: Basic Capabilities

Nanomedicine, Vol. I: Basic CapabilitiesAuthor: Robert A. Freitas Jr.
Publisher: Landes Bioscience
Category: Book

Buy Used: $105.54
as of 2/7/2012 20:54 PST details

In Stock
Buy

Used (5) from $105.54

Seller: owlsbooks

Languages: English (Unknown), English (Original Language), English (Published)
Media: Paperback
Edition: 1
Pages: 509
Number Of Items: 1
Shipping Weight (lbs): 2.5
Dimensions (in): 11 x 8.2 x 1.2

ISBN: 1570596808
EAN: 9781570596803

Shipping: Eligible for FREE Super Saver Shipping
Availability: Usually ships in 24 hours

Also Available In:

  • Hardcover - Nanomedicine, Volume I: Basic Capabilities

Editorial Reviews:

Product Description
Molecular nanotechnology has been defined as the three-dimensional positional control of molecular structure to create materials and devices to molecular precision. The human body is comprised of molecules, hence the availability of molecular nanotechnology will permit dramatic progress in human medical services. More than just an extension of "molecular medicine," nanomedicine will employ molecular machine systems to address medical problems, and will use molecular knowledge to maintain and improve human health at the molecular scale.

Nanomedicine will have extraordinary and far-reaching implications for the medical profession, for the definition of disease, for the diagnosis and treatment of medical conditions including aging, for our very personal relationships with our own bodies, and ultimately for the improvement and extension of natural human biological structure and function. This book will be published in three Volumes over the course of several years. The present Volume is the first in this series. Its intended audience is technical and professional people who are seriously interested in the future of medical technology -- particularly physical scientists, chemists, biochemists, and biomedical engineers engaged in basic research.


In Stock
Buy